Patients will ask for Qsymia

November 2012

Patients will ask for Qsymia...now that it's on the market.

Qsymia (kyoo-SIM-ee-uh) is a combination of low-dose phentermine plus extended-release topiramate for weight loss.

It's for patients with a BMI of at least 30...or BMI of 27 with a comorbid condition (diabetes, hypertension, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote